title: Linezolid-induced lactic acidosis followed by severe hypophosphatemia after discontinuation of linezolid.
authors: Atsushi
authors: A
authors: Miyawaki
authors: Takahiro
authors: T
authors: Ueda
authors: Atsunori
authors: A
authors: Nakao
authors: Masaru
authors: M
authors: Adachi
authors: Munehiko
authors: M
authors: Ohya
authors: Isamu
authors: I
authors: Yamada
authors: Yoshio
authors: Y
authors: Takesue
authors: Joji
authors: J
authors: Kotani
mesh_terms: D000081:Acetamides / Q000009:adverse effects* / Q000627:therapeutic use; D000140:Acidosis, Lactic / Q000097:blood* / Q000139:chemically induced*; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D017674:Hypophosphatemia / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D000069349:Linezolid; D008297:Male; D023303:Oxazolidinones / Q000009:adverse effects* / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D017680:Potassium Compounds / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000378:metabolism*
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D010710:Phosphates; D017680:Potassium Compounds; C013216:potassium phosphate; D000069349:Linezolid